Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, LLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of fiduciary duties and violations of the federal securities laws.

What is Johnson Fistel Investigating? Between April 30, 2020 and February 24, 2022, certain CareDX insiders allegedly caused the company to issue false and misleading public statements regarding its compliance with health care laws and its purported revenue growth. However, beginning on October 28, 2021, CareDx made its first in a series of public disclosures announcing that the company was facing multiple government investigations and that CareDx’s financial results were far lower than it had previously claimed. By the time the company made its final disclosure on November 3, 2022, the price of CareDx’s shares had plummeted by over 77.22%.

Current stockholders who have held their CareDx stock since at least January 2021, and still hold today are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: https://www.johnsonfistel.com/investigations/caredx-inc

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.